Diagnostic and Guided Interventional Cardiology Products Market
Diagnostic and Guided Interventional Cardiology Products Market
$4,750.00
This comprehensive medical market and technology report provides an overview and in-depth market analysis of diagnostic and guided interventional cardiology devices (specifically, transcatheter angiography, guidewire-based intravascular stenosis assessment, intracardiac echocardiography (ICE), intravascular ultrasound (IVUS), optical coherence tomography (OCT), and robotic-assisted surgical systems) used in the diagnosis of cardiovascular diseases (CVDs) and guidance of minimally invasive therapies.
Publisher: Meddevicetracker
- Description
- Contents
- Samples
The global market for diagnostic and guided interventional cardiology products is being driven by the increasing burden of cardiovascular disease (CVD). CVD is the leading cause of death globally, responsible for over 17 million deaths annually. This analysis includes a discussion of products, current/forecast markets, competitors, and opportunities in the global diagnostic and guided interventional cardiology products market, which includes transcatheter angiography, guidewire-based intravascular stenosis assessment, intracardiac echocardiography (ICE), intravascular ultrasound (IVUS), optical coherence tomography (OCT), and robotic-assisted surgical systems. Global product sales are projected to expand at a compound annual growth rate (CAGR) of 6.4% during 2016-21, increasing from approximately $3,491.3m in 2016 to an estimated $4,761.4m in 2021. Countries/regions covered by this report include the US, five major European markets (France, Germany, Italy, Spain, and the UK), Japan, and the Rest of the World segment (which combines estimated sales data for all other countries).
This analysis includes a discussion of products, competitors, market forecasts, and opportunities in the global market for diagnostic and guided interventional cardiology products.
Topics Covered Include:
- An overview of diagnostic and guided interventional cardiology devices, including transcatheter angiography, fraction flow reserve, intracardiac echocardiography (ICE), intravascular ultrasound, optical coherence tomography (OCT), as well as robotic-assisted surgical systems.
- Global and country/region-specific market forecasts, including forecasts by product segment.
- Competitive analyses by product segment.
- Discussion of key drivers and limiters impacting the major product segments.
- Country and region-specific insights that are influencing the utilization of diagnostic and guided interventional cardiology devices.
- A review of emerging technologies which could impact sales of existing devices.
Report Highlights:
- Diagnostic interventional cardiology products are being utilized less frequently in the preoperative work-up of patients with suspected cardiovascular disease. These technologies are primarily utilized to guide minimally invasive therapies (eg stenting).
- Angiography devices, including cardiac X-ray systems and transcatheter devices, accounted for 59% of total product sales in 2016. Sales of ICE and OCT systems are expected to experience the strongest growth throughout the forecast period (2016-21).
- The market for diagnostic and guided interventional cardiology devices is anticipated to experience moderate growth during the forecast period, increasing to an estimated $4.8bn by 2021.
- The increasing burden of cardiovascular diseases (CVDs) and the growing elderly demographic, a high risk demographic for the development of CVDs, are the main factors driving growth in product sales.
- The US market for diagnostic and guided interventional cardiology devices accounted for approximately 35% of all sales, followed by the five major European markets (France, Germany, Italy, Spain, and the UK). The strongest growth in biopsy product sales is expected to occur in the Rest of the World segment, which is being driven by demand for more sophisticated healthcare services in emerging markets.
EXECUTIVE SUMMARY …………………………………………………………………………. ES-1
i. Cardiovascular diseases overview …………………………………………. ES-1
ii. Global diagnostic and guided interventional cardiology products market …………………………………………………………………… ES-2
a. Selected market drivers and limiters ………………………… ES-5
b. Device segment insights…………………………………………. ES-5
c. Technology trends …………………………………………………. ES-6
iii. Methodology ……………………………………………………………………….. ES-7
Exhibit ES-1: Diagnostic and guided interventional cardiology products, global market forecast, 2016-21 …………………………………………….. ES-3
Exhibit ES-2: Global diagnostic and guided interventional cardiology products market, share by country/region, 2016 ………………………. ES-4
1. CARDIOVASCULAR DISEASES OVERVIEW …………………………………….. 1-1
1.1 Acute coronary syndrome ………………………………………………………… 1-3
1.1.1 Atherosclerosis ………………………………………………………… 1-5
1.1.2 Angina pectoris ………………………………………………………… 1-5
1.1.3 Myocardial infarction ………………………………………………… 1-6
1.2 Hypertension ……………………………………………………………………….. 1-10
1.3 Cardiomyopathy …………………………………………………………………… 1-13
1.4 Congenital heart defects ………………………………………………………… 1-13
1.5 Heart failure …………………………………………………………………………. 1-14
1.6 Peripheral vascular disease …………………………………………………… 1-18
1.7 Cerebrovascular disease ……………………………………………………….. 1-19
1.8 Bibliography …………………………………………………………………………. 1-23
Exhibit 1-1: Estimated mortality due to ischemic heart disease and cerebrovascular disease, select countries ………………………………….. 1-1
Exhibit 1-2: Top 10 countries with the highest CVD death rates……………………… 1-2
Exhibit 1-3: Estimated incidence rates for acute coronary syndrome, select countries ……………………………………………………………………… 1-4
Exhibit 1-4: Age-standardized incidence (000s) of angina pectoris, select regions …………………………………………………………………………… 6
Exhibit 1-5: Clinical classification of acute myocardial infarction ……………………. 1-7
Exhibit 1-6: Age-standardized incidence (000s) of acute myocardial infarction, select regions ………………………………………………………….. 1-9
Exhibit 1-7: Estimated incidence rates for myocardial infarction, select countries ……………………………………………………………………. 1-10
Exhibit 1-8: Estimated prevalence of hypertension, select countries ……………… 1-12
Exhibit 1-9: Mortality attributable to hypertensive diseases, select countries ….. 1-12
Exhibit 1-10: Age-standardized prevalence of heart failure, select regions ………. 1-17
Exhibit 1-11: Estimated prevalence of chronic heart failure, select countries ……. 1-17
Exhibit 1-12: Estimated incidence rates for stroke, select countries ………………… 1-21
Exhibit 1-13: Estimated prevalence of stroke, select countries ………………………. 1-22
2. DIAGNOSTIC AND GUIDED INTERVENTIONAL CARDIOLOGY
PRODUCTS ……………………………………………………………………………………. 2-1
2.1 Angiography ………………………………………………………………………….. 2-2
2.1.1 Angiography catheters ……………………………………………… 2-3
2.1.2 Angiography guidewires ……………………………………………. 2-6
2.1.3 Cardiovascular X-ray systems ……………………………………. 2-8
2.2 Fractional flow reserve ……………………………………………………………. 2-9
2.2.1 Fractional flow reserve products ……………………………….. 2-11
2.3 Intracardiac echocardiography ……………………………………………….. 2-12
2.3.1 Intracardiac echocardiography products ……………………. 2-14
2.4 Intravascular ultrasound ………………………………………………………… 2-17
2.4.1 Products ……………………………………………………………….. 2-19
2.5 Optical coherence tomography ……………………………………………….. 2-23
2.5.1 Products ……………………………………………………………….. 2-25
2.6 Robotic-assisted systems ………………………………………………………. 2-27
2.6.1 Products ……………………………………………………………….. 2-29
2.6.2 Emerging technology ………………………………………………. 2-33
2.7 Bibliography …………………………………………………………………………. 2-35
Exhibit 2-1: Advantages and disadvantages of conventional angiography ……….. 2-3
Exhibit 2-2: Select images of angiography catheters …………………………………….. 2-4
Exhibit 2-3: Selected angiography catheters and manufacturers ……………………. 2-5
Exhibit 2-4: Select images of angiography guidewires ………………………………….. 2-6
Exhibit 2-5: Selected angiography guidewires and manufacturers ………………….. 2-7
Exhibit 2-6: Select images of cardiac X-ray systems …………………………………….. 2-8
Exhibit 2-7: Selected cardiac X-ray systems and manufacturers …………………….. 2-9
Exhibit 2-8: Select images of FFR systems ……………………………………………….. 2-11
Exhibit 2-9: Selected fractional flow reserve systems and manufacturers ………. 2-12
Exhibit 2-10: Advantages and disadvantages of intracardiac echocardiography .. 2-13
Exhibit 2-11: Select images of intracardiac echocardiography systems …………… 2-16
Exhibit 2-12: Selected intracardiac echocardiography systems and manufacturers ………………………………………………………………… 2-17
Exhibit 2-13: Advantages and disadvantages of IVUS ………………………………….. 2-19
Exhibit 2-14: Select images of intravascular ultrasound systems ……………………. 2-22
Exhibit 2-15: Selected intravascular ultrasound systems and manufacturers ……. 2-23
Exhibit 2-16: Advantages and disadvantages of OCT …………………………………… 2-24
Exhibit 2-17: Select images of optical coherence tomography systems …………… 2-26
Exhibit 2-18: Selected optical coherence tomography systems and manufacturers ………………………………………………………………… 2-27
Exhibit 2-19: Advantages and disadvantages of robotic-assisted systems ………. 2-28
Exhibit 2-20: Select images of robotic-assisted systems ……………………………….. 2-32
Exhibit 2-21: Selected robotic-assisted systems and manufacturers ……………….. 2-33
3. DIAGNOSTIC AND GUIDED INTERVENTIONAL CARDIOLOGY
PRODUCTS MARKET ……………………………………………………………………… 3-1
3.1 Global competitors ………………………………………………………………… 3-13
3.1.1 Angiography systems competitive analysis ………………… 3-13
3.1.2 Fractional flow reserve systems competitive analysis ….. 3-14
3.1.3 Intracardiac echocardiography systems competitive analysis ……………………………………………….. 3-15
3.1.4 Intravascular ultrasound systems competitive analysis … 3-17
3.1.5 Optical coherence tomography systems competitive analysis ……………………………………………….. 3-18
3.1.6 Robotic-assisted surgical systems competitive analysis . 3-19
3.2 Market forecast: US ………………………………………………………………. 3-21
3.2.1 Angiography systems market …………………………………… 3-25
3.2.2 Fractional flow reservice systems market …………………… 3-27
3.2.3 Intracardiac echocardiography systems market ………….. 3-30
3.2.4 Intravascular ultrasound systems market …………………… 3-32
3.2.5 Optical coherence tomography systems market ………….. 3-34
3.2.6 Robotic-assisted surgical systems market ………………….. 3-35
3.3 Market forecast: five major EU markets ……………………………………. 3-38
3.3.1 Angiography systems market …………………………………… 3-43
3.3.2 Fractional flow reserve systems market …………………….. 3-45
3.3.3 Intracardiac echocardiography systems market ………….. 3-48
3.3.4 Intravascular ultrasound systems market …………………… 3-50
3.3.5 Optical coherence tomography systems market ………….. 3-52
3.3.6 Robotic-assisted surgical systems market ………………….. 3-55
3.4 Market forecast: Japan ………………………………………………………….. 3-57
3.4.1 Angiography systems market …………………………………… 3-61
3.4.2 Fractional flow reserve systems market …………………….. 3-63
3.4.3 Intracardiac echocardiography systems market ………….. 3-66
3.4.4 Intravascular ultrasound systems market …………………… 3-68
3.4.5 Optical coherence tomography systems market ………….. 3-69
3.4.6 Robotic-assisted surgical systems market ………………….. 3-71
3.5 Market forecast: RoW ……………………………………………………………. 3-74
3.5.1 Angiography systems market …………………………………… 3-78
3.5.2 Fractional flow reserve systems market …………………….. 3-81
3.5.3 Intracardiac echocardiography systems market ………….. 3-84
3.5.4 Intravascular ultrasound systems market …………………… 3-86
3.5.5 Optical coherence tomography systems market ………….. 3-88
3.5.6 Robotic-assisted surgical systems market ………………….. 3-90
3.6 Bibliography …………………………………………………………………………. 3-93
Exhibit 3-1: Diagnostic and guided interventional cardiology products, global market forecast ($m), 2016-21 …………………………………………………. 3-3
Exhibit 3-2: Diagnostic and guided interventional cardiology product sales by product segment, combined market forecast ($m), 2016-21 …………. 3-4
Exhibit 3-3: Average sale price of selected diagnostic and guided interventional cardiology products ………………………………………………………………… 3-6
Exhibit 3-4: Global diagnostic and guided interventional cardiology products market, share by country/region, 2016 …………………………………….. 3-10
Exhibit 3-5: Global diagnostic and guided interventional cardiology product sales by country/region, combined market forecast ($m), 2016-21 ………. 3-11
Exhibit 3-6: Global angiography devices market, share by supplier, 2016 ……… 3-14
Exhibit 3-7: Global fractional flow reserve systems market, share by supplier, 2016 ………………………………………………………………….. 3-15
Exhibit 3-8: Global intracardiac echocardiography systems market, share by supplier, 2016 ………………………………………………………………………. 3-16
Exhibit 3-9: Global intravascular ultrasound systems market, share by supplier, 2016 ………………………………………………………………….. 3-17
Exhibit 3-10: Global optical coherence tomography systems market, share by supplier, 2016 ………………………………………………………………………. 3-19
Exhibit 3-11: Global robotic-assisted surgical systems market, share by supplier, 2016 ………………………………………………………………….. 3-20
Exhibit 3-12: US Diagnostic and guided interventional cardiology product sales by product segment, combined market forecast ($m), 2016-21 …… 3-23
Exhibit 3-13: US angiography systems, market forecast ($m), 2016-21 …………… 3-26
Exhibit 3-14: US angiography devices market, share by supplier, 2016 …………… 3-27
Exhibit 3-15: US fractional flow reserve systems, market forecast ($m), 2016-21 ………………………………………………………….. 3-28
Exhibit 3-16: US fractional flow reserve systems market, share by supplier, 2016 ………………………………………………………………….. 3-29
Exhibit 3-17: US intracardiac echocardiography systems, market forecast ($m), 2016-21 ……………………………………………….. 3-31
Exhibit 3-18: US intracardiac echocardiography systems market, share by supplier, 2016 ………………………………………………………………….. 3-32
Exhibit 3-19: US intravascular ultrasound systems, market forecast ($m), 2016-21 ………………………………………………………….. 3-33
Exhibit 3-20: US intravascular ultrasound systems market, share by supplier, 2016 ………………………………………………………………….. 3-34
Exhibit 3-21: US optical coherence tomography systems, market forecast ($m), 2016-21 ……………………………………………….. 3-35
Exhibit 3-22: US robotic-assisted surgical systems, market forecast ($m), 2016-21 ……………………………………………….. 3-37
Exhibit 3-23: US robotic-assisted surgical systems market, share by supplier, 2016 ………………………………………………………………….. 3-38
Exhibit 3-24: 5EU Diagnostic and guided interventional cardiology product sales by product segment, combined market forecast ($m), 2016-213-41
Exhibit 3-25: 5EU angiography systems, market forecast ($m), 2016-21 …………. 3-44
Exhibit 3-26: 5EU angiography devices market, share by supplier, 2016 …………. 3-45
Exhibit 3-27: 5EU fractional flow reserve systems, market forecast ($m), 2016-21 ………………………………………………………….. 3-47
Exhibit 3-28: 5EU fractional flow reserve systems market, share by supplier, 2016 ………………………………………………………………….. 3-48
Exhibit 3-29: 5EU intracardiac echocardiography systems, market forecast ($m), 2016-21 ……………………………………………….. 3-49
Exhibit 3-30: 5EU intracardiac echocardiography systems market, share by supplier, 2016 ………………………………………………………………….. 3-50
Exhibit 3-31: 5EU intravascular ultrasound systems, market forecast ($m), 2016-21 ……………………………………………….. 3-51
Exhibit 3-32: 5EU intravascular ultrasound systems market, share by supplier, 2016 ………………………………………………………………….. 3-52
Exhibit 3-33: 5EU optical coherence tomography systems, market forecast ($m), 2016-21 ……………………………………………….. 3-54
Exhibit 3-34: 5EU optical coherence tomography systems market, share by supplier, 2016 ………………………………………………………………….. 3-55
Exhibit 3-35: 5EU robotic-assisted surgical systems, market forecast ($m), 2016-21 ……………………………………………….. 3-56
Exhibit 3-36: 5EU robotic-assisted surgical systems market, share by supplier, 2016 ………………………………………………………………….. 3-57
Exhibit 3-37: Japan Diagnostic and guided interventional cardiology product sales by product segment, combined market forecast ($m), 2016-21 ………………………………………………………………………………. 3-59
Exhibit 3-38: Japan angiography systems, market forecast ($m), 2016-21 ………. 3-62
Exhibit 3-39: Japan angiography devices market, share by supplier, 2016 ………. 3-63
Exhibit 3-40: Japan fractional flow reserve systems, market orecast ($m), 2016-21 ………………………………………………………….. 3-64
Exhibit 3-41: Japan fractional flow reserve systems market, share by supplier, 2016 ………………………………………………………………….. 3-65
Exhibit 3-42: Japan intracardiac echocardiography systems, market forecast ($m), 2016-21 ……………………………………………….. 3-66
Exhibit 3-43: Japan intracardiac echocardiography systems market, share by supplier, 2016 ………………………………………………………………….. 3-67
Exhibit 3-44: Japan intravascular ultrasound systems, market forecast ($m), 2016-21 ………………………………………………………….. 3-68
Exhibit 3-45: Japan intravascular ultrasound systems market, share by supplier, 2016 ………………………………………………………………….. 3-69
Exhibit 3-46: Japan optical coherence tomography systems, market forecast ($m), 2016-21 ……………………………………………….. 3-70
Exhibit 3-47: Japan optical coherence tomography systems market, share by supplier, 2016 ………………………………………………………………………. 3-71
Exhibit 3-48: Japan robotic-assisted surgical systems, market forecast ($m), 2016-21 ……………………………………………….. 3-73
Exhibit 3-49: Japan robotic-assisted surgical systems market, share by supplier, 2016 ………………………………………………………………….. 3-74
Exhibit 3-50: RoW diagnostic and guided interventional cardiology product sales by product segment, combined market forecast ($m), 2016-213-75
Exhibit 3-51: RoW angiography systems, market forecast ($m), 2016-21 ………… 3-80
Exhibit 3-52: RoW angiography devices market, share by supplier, 2016 ………… 3-81
Exhibit 3-53: RoW fractional flow reserve systems, market forecast ($m), 2016-21 ………………………………………………………….. 3-82
Exhibit 3-54: RoW fractional flow reserve systems market, share by supplier, 2016 ………………………………………………………………….. 3-83
Exhibit 3-55: RoW intracardiac echocardiography systems, market forecast ($m), 2016-21 ………………………………………………………….. 3-85
Exhibit 3-56: RoW intracardiac echocardiography systems market, share by supplier, 2016 ………………………………………………………………………. 3-86
Exhibit 3-57: RoW intravascular ultrasound systems, market forecast ($m), 2016-21 ………………………………………………………….. 3-87
Exhibit 3-58: RoW intravascular ultrasound systems market, share by supplier, 2016 ………………………………………………………………….. 3-88
Exhibit 3-59: RoW optical coherence tomography systems, market forecast ($m), 2016-21 ………………………………………………………….. 3-89
Exhibit 3-60: RoW optical coherence tomography systems market, share by supplier, 2016 ………………………………………………………………………. 3-90
Exhibit 3-61: RoW robotic-assisted surgical systems, market forecast ($m), 2016-21 ………………………………………………………….. 3-91
Exhibit 3-62: RoW robotic-assisted surgical systems market, share by supplier, 2016 ………………………………………………………………….. 3-92
APPENDIX: COMPANY LISTING ……………………………………………………………… A-1
© Pharma Intelligence UK Ltd. This document is a licensed product and is not to be reproduced or redistributed
Do you have a subscription to Datamonitor Healthcare, Biomedtracker or Meddevicetracker? You may already have access to these reports, contact your account manager or email pharma@informabi.com for further help or assistance.
Biomedtracker Q3 2017 Outlook Report 
Sign up to the